2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Mumps: new trials by email Literature Review of Mumps trials Research Report on Mumps
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11 Attenuated Mumps vaccine (KMB-17) in phase II and III, Placebo in phase II, Attenuated Mumps vaccine (KMB-17) in phase III - Epidemic Parotitis, Mumps | Phase 2 / Phase 3 | Unknown | Institute of Medical Biology, Chinese Academy of Medical Sciences | 11999 | 2020-10-12 | 2023-10-11 |
| Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants ≥3.0 lgCCID50/mlbut <3.5lgCCID50/ml Live Attenuated Mumps Vaccine (Human Diploid Cell) in infants(8-24 months old), ≥4.5 lgCCID50/ml Live Attenuated Mumps Vaccine (Human Diploid Cell) in infants(8-24 months old), Measles and Mumps Combined Vaccine，Live(SIBP)( positive control) - Epidemic Parotitis,Mumps | Phase 2 | Unknown | Institute of Medical Biology, Chinese Academy of Medical Sciences | 1080 | 2017-05-20 | 2023-10-10 |
Infections (2) · Mononegavirales Infections (2) · Mouth Diseases (2) · Paramyxoviridae Infections (2) · Parotid Diseases (2) · Parotitis (2) · RNA Virus Infections (2) · Rubulavirus Infections (2) · Salivary Gland Diseases (2) · Stomatognathic Diseases (2) · Virus Diseases (2)
Clinical Trials, Phase II as Topic (1) · Clinical Trials, Phase III as Topic (1) · Mumps Vaccine (1)
Institute of Medical Biology, Chinese Academy of Medical Sciences (2)
China (2)
Beifang Yang, PhD (1) · Qihan Li (1)